EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives

Igor A Schepetkin, Zhangeldy S Nurmaganbetov, Serik D Fazylov, Oralgazy A Nurkenov, Andrei I Khlebnikov iD, Tulegen M Seilkhanov iD, Anarkul S Kishkentaeva, Elvira E Shults iD, Mark T Quinn iD

Molecules · 11.04.2023 · 28 (8) · 3357

DOI: 10.3390/molecules28083357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 11.04.2023. Verfasst von Igor A Schepetkin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health IDeA Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive memory loss and cognitive impairment due in part to a severe loss of cholinergic neurons in specific brain areas. AD is the most common type of dementia in the aging population. Although several acetylcholinesterase (AChE) inhibitors are currently available, their performance sometimes yields unexpected results. Thus, research is ongoing to find potentially therapeutic AChE inhibitory agents, both from natural and synthetic sources. Here, we synthesized 13 new lupinine triazole derivatives and evaluated them, along with 50 commercial lupinine-based esters of different carboxylic acids, for AChE inhibitory activity. The triazole derivative 15 [1S,9aR)-1-((4-(4-(benzyloxy)-3-methoxyphenyl)-1H-1,2,3-triazol-1-yl)methyl)octahydro-2H-quinolizine)] exhibited the most potent AChE inhibitory activity among all 63 lupinine derivatives, and kinetic analysis demonstrated that compound 15 was a mixed-type AChE inhibitor. Molecular docking studies were performed to visualize interaction between this triazole derivative and AChE. In addition, a structure-activity relationship (SAR) model developed using linear discriminant analysis (LDA) of 11 SwissADME descriptors from the 50 lupinine esters revealed 5 key physicochemical features that allowed us to distinguish active versus non-active compounds. Thus, this SAR model could be applied for design of more potent lupinine ester-based AChE inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAlzheimer DiseaseHumansAgedMolecular Docking SimulationAcetylcholinesteraseKineticsCholinesterase InhibitorsStructure-Activity RelationshipTriazolesQuinolizidine Alkaloids

Stichwörter der Autor:innen

Alzheimer’s diseaseacetylcholinesteraseacetylcholinesterase inhibitoresterlupininemolecular dockingtriazole derivative

Substanzen

AcetylcholinesteraseCholinesterase InhibitorsTriazoleslupinineQuinolizidine Alkaloids

Autor:innen und Institutionen

  • Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.
  • Institute of Organic Synthesis and Coal Chemistry, Karaganda 100008, Kazakhstan.
  • School of Pharmacy, Medical University of Karaganda, Karaganda 100012, Kazakhstan.
  • Kizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Laboratory of Engineering Profile NMR Spectroscopy, Sh. Ualikhanov Kokshetau University, Kokshetau 020000, Kazakhstan.
  • N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

ORCID-Profile: Andrei I Khlebnikov, Tulegen M Seilkhanov, Elvira E Shults, Mark T Quinn

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health IDeA Program
  • USDA National Institute of Food and Agriculture Hatch
  • Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan
  • Tomsk Polytechnic University Development Program
  • Montana State University Agricultural Experiment Station

Zitieren

APA

Schepetkin, I. A., Nurmaganbetov, Z. S., Fazylov, S. D., Nurkenov, O. A., Khlebnikov, A. I., Seilkhanov, T. M., Kishkentaeva, A. S., Shults, E. E., & Quinn, M. T. (2023). Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives. Molecules, 28(8), 3357. https://doi.org/10.3390/molecules28083357

Vancouver

Schepetkin IA, Nurmaganbetov ZS, Fazylov SD, Nurkenov OA, Khlebnikov AI, Seilkhanov TM, et al. Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives. Molecules. 2023;28(8):3357. doi:10.3390/molecules28083357

BibTeX
@article{Schepetkin2023,
  author = {Schepetkin, Igor A and Nurmaganbetov, Zhangeldy S and Fazylov, Serik D and Nurkenov, Oralgazy A and Khlebnikov, Andrei I and Seilkhanov, Tulegen M and Kishkentaeva, Anarkul S and Shults, Elvira E and Quinn, Mark T},
  title = {Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {8},
  pages = {3357},
  doi = {10.3390/molecules28083357}
}
Kostenlos starten →